ENDRA Life Sciences Inc. NDRA
4.80 USD +0.05 +1.05%
At close · Nov 2
4.51 -0.29 -6.04%
After hours · Nov 2, 4:00 PM ET
- Open
- 4.71
- Prev close
- 4.75
- Mkt cap
- 7.20M
- Vol
- 5.78K
- Avg vol
- 31.14K
- EPS
- -6.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.64
- High
- 4.89
- Forward P/E
- -0.02
- Beta
- 0.74
- Short ratio
- 0.05
- Inst. own
- 0.49%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.68
- 200-d avg
- 291.96
- 1y target
- 2,625.00
5Y chart
Chart tools
Chart is warming up
The five-year price history for NDRA has not been loaded yet. Try again in a moment.
Altman Z-Score
-19.47 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
P/E -0.5×
P/S 0.0×
P/B 1.6×
P/FCF -0.7×
EV/EBITDA -0.5×
EV/Sales 0.0×
FCF Yield -145.8%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -310.9%
ROIC -178.3%
ROA -182.4%
Revenue 0.0%
Operating Income 46.7%
EPS (diluted) 12.9%
Free Cash Flow 29.9%
Current Ratio 1.3×
Quick Ratio 1.3×
Debt / Equity 0.2×
Net Debt / EBITDA 0.0×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31